Literature DB >> 20148887

Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.

Elizabeth E Gardiner, James Y Thom, Mohammad Al-Tamimi, Annette Hughes, Michael C Berndt, Robert K Andrews, Ross I Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20148887     DOI： 10.1111/j.1365-2141.2010.08092.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Romiplostim as early treatment for refractory primary immune thrombocytopenia.

Authors:  Anne Contis; Estibaliz Lazaro; Carine Greib; Jean-Luc Pellegrin; Jean-François Viallard
Journal:  Int J Hematol       Date:  2013-09-26       Impact factor: 2.490

2.  Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.

Authors:  John R Stack; Anne Madigan; Laura Helbert; Eimear Dunne; Elizabeth E Gardiner; Robert K Andrews; Roisin Finan; Elizabeth Smyth; Dermot Kenny; Geraldine M McCarthy
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

3.  Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity?

Authors:  David J Rabbolini; Elizabeth E Gardiner; Marie-Christine Morel-Kopp; Scott Dunkley; Anila Jahangiri; Christine S-M Lee; William S Stevenson; Christopher M Ward
Journal:  Res Pract Thromb Haemost       Date:  2017-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.